$2.56
6.91% yesterday
Nasdaq, Nov 15, 10:00 pm CET
ISIN
CA74880P1045
Symbol
QIPT

Quipt Home Medical Corp - Ordinary Shares New Target price 2024 - Analyst rating & recommendation

Quipt Home Medical Corp - Ordinary Shares New Classifications & Recommendation:

Buy
100%

Quipt Home Medical Corp - Ordinary Shares New Price Target

Target Price $7.79
Price $2.56
Potential
Number of Estimates 6
6 Analysts have issued a price target Quipt Home Medical Corp - Ordinary Shares New 2025 . The average Quipt Home Medical Corp - Ordinary Shares New target price is $7.79. This is higher than the current stock price. The highest price target is , the lowest is .
A rating was issued by 6 analysts: 6 Analysts recommend Quipt Home Medical Corp - Ordinary Shares New to buy, 0 to hold and 0 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the Quipt Home Medical Corp - Ordinary Shares New stock has an average upside potential 2025 of . Most analysts recommend the Quipt Home Medical Corp - Ordinary Shares New stock at Purchase.

Sales and Margin forecast 2024, 2025 & 2026

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Sep '23 2024
Estimates
Revenue Million $ 221.74 258.18
58.54% 16.44%
EBITDA Margin 20.42% 22.52%
20.35% 10.28%
Net Margin -1.36% 1.67%
131.54% 222.77%

6 Analysts have issued a sales forecast Quipt Home Medical Corp - Ordinary Shares New 2024 . The average Quipt Home Medical Corp - Ordinary Shares New sales estimate is

$258m
Unlock
. This is
0.93% higher
Unlock
than the revenue of the last 12 months(TTM). The highest sales forecast is
$260m 1.56%
Unlock
, the lowest is
$257m 0.47%
Unlock
.

This results in the following potential growth metrics:

Revenue Estimates

2023 $222m 58.54%
2024
$258m 16.44%
Unlock
2025
$268m 3.93%
Unlock
2026
$281m 4.53%
Unlock

6 Analysts have issued an Quipt Home Medical Corp - Ordinary Shares New EBITDA forecast 2024. The average Quipt Home Medical Corp - Ordinary Shares New EBITDA estimate is

$58.1m
Unlock
. This is
7.79% higher
Unlock
than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is
$59.5m 10.31%
Unlock
, the lowest is
$55.8m 3.45%
Unlock
.

This results in the following potential growth metrics and future EBITDA Margins:

EBITDA Estimates

2023 $45.3m 90.81%
2024
$58.1m 28.41%
Unlock
2025
$60.3m 3.67%
Unlock
2026
$64.0m 6.19%
Unlock

EBITDA Margin

2023 20.42% 20.35%
2024
22.52% 10.28%
Unlock
2025
22.46% 0.27%
Unlock
2026
22.82% 1.60%
Unlock

The average Quipt Home Medical Corp - Ordinary Shares New net profit estimate is

$4.3m
Unlock
. This is
183.35% higher
Unlock
than the net profit for the last 12 months(TTM).

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2023 $-3.0m 150.00%
2024
$4.3m 242.89%
Unlock
2025
$15.1m 249.88%
Unlock

Net Margin

2023 -1.36% 131.54%
2024
1.67% 222.77%
Unlock
2025
5.62% 236.53%
Unlock

Earnings per share, P/E ratio and EV/sales Estimates 2024, 2025 & 2026

Create a premium account to unlock analyst estimates. Learn more

Sep '23 2024
Estimates
Earnings Per Share $ -0.07 0.10
150.00% 242.86%
P/E 25.60
EV/Sales 0.75

The average Quipt Home Medical Corp - Ordinary Shares New <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS is

$0.10
Unlock
. This is
183.33% higher
Unlock
than earnings per share in the financial year 2023.

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2023 $-0.07 150.00%
2024
$0.10 242.86%
Unlock
2025
$0.35 250.00%
Unlock

P/E ratio

Current -21.57 105.80%
2024
25.60 218.68%
Unlock
2025
7.31 71.45%
Unlock

Based on analysts' sales estimates for 2024, the Quipt Home Medical Corp - Ordinary Shares New stock is valued at an <a href=https://blog.stocksguide.com/knowledge/enterprise-value-sales-simply-explained>EV/Sales of

and an <a href=https://blog.stocksguide.com/knowledge/price-sales-ratio-simply-explained>P/S ratio of .

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 0.76 45.32%
2024
0.75 0.84%
Unlock
2025
0.73 3.78%
Unlock
2026
0.69 4.34%
Unlock

P/S ratio

Current 0.43 57.09%
2024
0.43 0.90%
Unlock
2025
0.41 3.79%
Unlock
2026
0.39 4.33%
Unlock

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today